About Bioline  All Journals  Testimonials  Membership  News

Rwanda Medical Journal
Rwanda Health Communication Center - Rwanda Biomedical Center (RHCC - RBC)
ISSN: 2079-097X
EISSN: 2079-097X
Vol. 78, No. 2, 2021, pp. 22-28
Bioline Code: rw21012
Full paper language: English
Document type: Research Article
Document available free of charge

Rwanda Medical Journal, Vol. 78, No. 2, 2021, pp. 22-28

 en Prevalence and Risk Factors of Otitis Media with Effusion in Patients with Adenoid Hypertrophy at Kigali University Teaching Hospital – A Cross-Sectional Study
Umutoni, J. & Mugabo, R.


BACKGROUND: Otitis media with effusion (OME) is a middle ear effusion without signs and symptoms of middle ear infections. It is mainly due to Eustachian tube dysfunction or sequelae of acute otitis media. There are different risks predisposing to OME (otitis media with effusion), among them adenoid hypertrophy.
METHODS: This study was conducted at a tertiary hospital in Kigali, Rwanda. Children (1 to 12 years of age) with symptoms and signs of adenoid hypertrophy were included in the study. Questions about risk factors of OME were asked, then a physical examination with pneumatic otoscopy and fiberoptic nasopharyngoscopy were done as investigation tympanometry was performed to confirm the presence of OME.
RESULTS: 152 children met the inclusion criteria. The prevalence of otitis media with effusion was 46%. The age group 1-4 years was highly associated with OME (p=0.024). Low Socioeconomic Status (Ubudehe category 2 and 3) was also associated with OME (p<0.05), accounting for 75% of patients. Attending daycare centers, parents with OME, previous acute otitis media (AOM), smoking at home, bottle feeding and feeding while supine, were not shown to be risk factors.
CONCLUSION: Otitis media with effusion is highly prevalent in children with adenoid hypertrophy. Proper examination is mandatory to prevent possible sequels from unnoticed OME.

Adenoid Hypertrophy; Otitis Media With Effusion; Risk Factors

© Copyright 2021 - The Author(s)
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil